ArticleJournal of thoracic disease2025

The role of targetable biomarker alterations in overall survival for non-small cell lung cancer (NSCLC) in a large integrated health system.

Alberto Jarrin Lopez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.